Prostate Cancer: October 2006 Archives

prostate cancer

Men who receive hormone therapy for prostate cancer with drugs called gonadotropin-releasing hormone (GnRH) agonists may find themselves at higher risk for diabetes and heart disease. Doctors and patients should take this into account when deciding whether GnRH agonist treatment is appropriate, according to a study by Harvard Medical School researchers published in the Journal of Clinical Oncology.

GnRH agonists are also called LHRH agonists. Common drugs in this class include leuprolide (Lupron, Viadur, Eligard), goserelin (Zoladex), and triptorelin (Trelstar).

The goal of hormone therapy for prostate cancer is to reduce levels of testosterone, the male hormone that is known to fuel the growth of the cancer. Hormone therapy is typically given for prostate cancer when it has spread to other parts of the body or has come back after treatment with surgery or radiation. It is also given before radiation in early stages of the cancer to make the tumor easier to treat. The authors say the use of hormone therapy in men with earlier stage prostate cancer has been increasing in recent years.

7 Keys to Prostate Cancer Management

|

THURSDAY, Oct. 19 (HealthDay News) -- Early detection and treatment are crucial to defeat prostate cancer, says a Johns Hopkins Health Alerts report that outlines seven key ways to treat prostate cancer and provides advice on how to prevent it.

The 7 Keys to Treating Prostate Cancer report was written by Dr. Jacek L. Mostwin of Johns Hopkins' James Buchanan Brady Urological Institute. The report is meant to help prostate cancer patients make informed decisions about their medical care.

By Janice Billingsley, HealthDay, 6 Oct 2006

FRIDAY, Oct. 6 (HealthDay News) -- Doctors have long known that lowering your cholesterol levels helps protect your heart. But could it also reduce the risk of prostate cancer for men?

Researchers are increasingly optimistic that the two conditions are related, making what's good for the heart good for the prostate, too.

About this Archive

This page is a archive of entries in the Prostate Cancer category from October 2006.

Prostate Cancer: November 2006 is the next archive.

Find recent content on the main index or look in the archives to find all content.